GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Sloan Ratio %

Steep Hill (XCNQ:STPH) Sloan Ratio % : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Steep Hill Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Steep Hill's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

Warning Sign:

When sloan ratio (74.39)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2023, Steep Hill has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Steep Hill Sloan Ratio % Historical Data

The historical data trend for Steep Hill's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill Sloan Ratio % Chart

Steep Hill Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
5.04 -32.53 -35.30 -224.80 74.39

Steep Hill Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Steep Hill's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steep Hill's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Steep Hill's Sloan Ratio % falls into.



Steep Hill Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Steep Hill's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(0.793-0.742
--2)/2.757
=74.39%

Steep Hill's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(0.793-0.743
--2)/2.757
=74.36%

Steep Hill's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 2.012 (Mar. 2023 ) + -0.352 (Jun. 2023 ) + -0.898 (Sep. 2023 ) + 0.031 (Dec. 2023 ) = C$0.79 Mil.
Steep Hill's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 1.915 (Mar. 2023 ) + -0.36 (Jun. 2023 ) + -0.272 (Sep. 2023 ) + -0.54 (Dec. 2023 ) = C$0.74 Mil.
Steep Hill's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -2 (Mar. 2023 ) + -0.656 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0.656 (Dec. 2023 ) = C$-2.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Steep Hill  (XCNQ:STPH) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Steep Hill has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Steep Hill Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Steep Hill's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Steep Hill (XCNQ:STPH) Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines